ATRC compared with OMCL: revenue, margins and what each company keeps, and the suppliers and customers both name

ATRCAtriCure, Inc.

Mkt capRevenueRevenue

OMCLOmnicell, Inc.

Mkt capRevenueRevenue

Compare

ATRCAtriCure, Inc.

OMCLOmnicell, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

ATRC

0 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±15.5%▲+6.18%×0.40

Q1 FY26±12.9%▼−4.70%×0.36

Feb 18 '26±14.3%▼−2.15%×0.15

Jan 12 '26±10.8%▼−9.21%×0.85

OMCL

2 of 4at or beyond implied

Reportimpliedrealized× implied

Oct 29 '26thin chain±15.9%▲+2.59%×0.16

Q2 FY26±14.3%▼−10.36%×0.73

= impliedATRC realized, solidOMCL realized, hatchedOne scale, both sides: full bar = 21%× = |realized| ÷ impliedSource: market data

Q1 FY26±14.6%▲+20.94%×1.43

Feb 5 '26±14.9%▼−16.30%×1.09

ATRCAtriCure, Inc.

59.81· pre 57.00· delayed

Mkt cap$3.1BRevenue$154MQ2 FY26Revenue$535MFY25

OMCLOmnicell, Inc.

36.39· pre 36.45· delayed

Pre-marketNov 3 '26delayed

Mkt cap$1.7BRevenue$312MQ2 FY26Revenue$1.2BFY25

Compare

Pre-marketNov 3 '26delayed

ATRCAtriCure, Inc.

OMCLOmnicell, Inc.

59.81pre 57.00delayed

Price

36.39pre 36.45delayed

$3.1B

Mkt cap

$1.7B

Q2 FY26$154M

Revenue

$312MQ2 FY26

FY25$535M

Revenue

$1.2BFY25

ATRC59.81vsOMCL36.39Pre-marketNov 3 '26delayed